123 filings
8-K
APTO
Aptose Biosciences Inc
26 Apr 24
Entry into a Material Definitive Agreement
7:30am
8-K
APTO
Aptose Biosciences Inc
5 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:05pm
8-K
APTO
Aptose Biosciences Inc
26 Mar 24
Aptose Reports Results for the Fourth Quarter and Full Year 2023
4:04pm
8-K
APTO
Aptose Biosciences Inc
18 Mar 24
Regulation FD Disclosure
4:45pm
8-K
APTO
Aptose Biosciences Inc
1 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
nxab9s009clj
31 Jan 24
Regulation FD Disclosure
4:02pm
8-K
34bwy
29 Jan 24
Entry into a Material Definitive Agreement
9:44pm
8-K
x46tovrxny6 dkw
26 Jan 24
Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical
8:00am
8-K
qj09 2eerdnjel0
11 Dec 23
Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting
6:30am
8-K
37w068 l3zi
30 Nov 23
Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role
5:28pm
8-K
7e4b 1k3d
9 Nov 23
Aptose Reports Results for the Third Quarter 2023
4:15pm
8-K
ccl dpol7ra
2 Nov 23
Aptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meeting
9:15am
8-K
x6mdawb58rccitahi82i
30 Oct 23
Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib
9:20am
8-K
d71xb 14l0
26 Oct 23
Regulation FD Disclosure
10:12am
8-K
r5o3dqnyuc37 4nditu
23 Oct 23
Aptose to Hold Clinical Update and KOL Data Review of AML Drug Tuspetinib on Monday, October 30th
8:00am
8-K
263ecky9cnvy 9ub
16 Oct 23
Aptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th International Conference
8:00am
8-K
4iui wm3a7
18 Sep 23
Aptose to Present at the Cantor Global Healthcare Conference
8:00am
8-K
pcr blp3ut2rm5
12 Sep 23
Entry into a Material Definitive Agreement
4:30pm
8-K
92wcw6
6 Sep 23
Aptose Announces Closing of $3 Million Investment by Hanmi Pharmaceutical
8:01am
8-K
u3bj8nnb j8
24 Aug 23
Aptose to Present at the H.C. Wainwright 25th Annual Global Investment Conference
8:00am